P1303 AN INTERFERON- AND RIBAVIRIN-FREE 12-WEEK REGIMEN OF ONCE-DAILY VX-135 AND DACLATASVIR IN TREATMENT-NAÏVE PATIENTS WITH GENOTYPE 1 HCV INFECTION